Search research articles
Contact Us
Filters
Showing results (181-190 of 224) with videos related to
Page
of 23
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
February 3, 2023
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415
Jinbing Bai, Stephanie L Pugh, Ronald Eldridge, et al.
European Urology
|
January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial
Loren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 2, 2023
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Himanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study
Anamaria R Yeung, Stephanie L Pugh, Ann H Klopp, et al.
JAMA Oncology
|
March 14, 2024
Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial
Mark K Buyyounouski, Stephanie L Pugh, Ronald C Chen, et al.
European Urology Oncology
|
November 14, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials
Krishnan R Patel, Paul L Nguyen, James A Proudfoot, et al.
Gynecologic Oncology
|
May 21, 2019
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy
Karen M Gil, Stephanie L Pugh, Ann H Klopp, et al.
Advances in Radiation Oncology
|
April 20, 2026
The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202
Krishnan R Patel, Stephanie L Pugh, Jeffry P Simko, et al.
JCO Oncology Advances
|
May 15, 2025
Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203
Kelsey L Corrigan, Rebecca Paulus, Ann H Klopp, et al.
Neuro-Oncology Advances
|
October 27, 2022
Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825
Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 224) with videos related to
Sort By:
Page
of 23
International Journal of Radiation Oncology, Biology, Physics
|
February 3, 2023
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415
Jinbing Bai, Stephanie L Pugh, Ronald Eldridge, et al.
European Urology
|
January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial
Loren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 2, 2023
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Himanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study
Anamaria R Yeung, Stephanie L Pugh, Ann H Klopp, et al.
JAMA Oncology
|
March 14, 2024
Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial
Mark K Buyyounouski, Stephanie L Pugh, Ronald C Chen, et al.
European Urology Oncology
|
November 14, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials
Krishnan R Patel, Paul L Nguyen, James A Proudfoot, et al.
Gynecologic Oncology
|
May 21, 2019
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy
Karen M Gil, Stephanie L Pugh, Ann H Klopp, et al.
Advances in Radiation Oncology
|
April 20, 2026
The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202
Krishnan R Patel, Stephanie L Pugh, Jeffry P Simko, et al.
JCO Oncology Advances
|
May 15, 2025
Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203
Kelsey L Corrigan, Rebecca Paulus, Ann H Klopp, et al.
Neuro-Oncology Advances
|
October 27, 2022
Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825
Michael E Scheurer, Renke Zhou, Mark R Gilbert, et al.
Page
of 23